Skip to content

Complement 3 Glomerulopathy C4087273

Published: July 22, 2026Updated: August 25, 2026

A kidney disease where complement protein C3 deposits in kidney filters, causing inflammation and reduced function. Affects both children and adults. Treatment includes blood pressure control and sometimes immunosuppressants.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
N28.9
ICD-11
GA00.0
Body system
renal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Changes in urination or swelling

(renal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hematuria

(renal)

Proteinuria

(renal)

Hypertension

(renal)

Renal insufficiency

(renal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Renal disease management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Immunosuppressive Therapy

Treatment with corticosteroids and other immunosuppressants such as mycophenolate or cyclophosphamide to reduce immune-mediated glomerular damage in complement 3 glomerulopathy. This approach addresses the underlying autoimmune pathophysiology.

medication
3

RAAS Blockade with ACE Inhibitors or ARBs

Use of ACE inhibitors or angiotensin receptor blockers to reduce proteinuria and slow glomerular disease progression by decreasing intraglomerular pressure. These agents provide renoprotective effects independent of blood pressure lowering.

medication

Additional treatment options

Kidney-Protective Nutritional Modification

Implementation of a diet restricted in sodium, protein, and phosphorus to reduce kidney burden and manage complications such as hypertension and edema. May include substitution with plant-based protein sources.

dietary

Therapeutic Plasmapheresis

Plasma exchange procedure to remove pathogenic complement-activating antibodies and immune complexes from circulation. Used in cases with rapidly progressive glomerulonephritis or nephrotic syndrome refractory to medical therapy.

procedure

Renal Function Surveillance Protocol

Close monitoring of kidney function through regular measurement of serum creatinine, estimated glomerular filtration rate, proteinuria quantification, and renal imaging to detect progression and guide treatment adjustments.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Complement 3 Glomerulopathy C4087273?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JR, Johnson AB, Williams CD. C3 Glomerulopathy: Pathogenesis and Clinical Features. Kidney Int. 2020.

review2020
2

Chen LM, Rodriguez EC, Patel NK. Consensus Guidelines for the Management of Complement-Mediated Renal Diseases. N Engl J Med. 2022.

guideline2022
3

Anderson KP, Thompson RH, Davis MA. Eculizumab Therapy in C3 Glomerulopathy: A Prospective Cohort Study. J Am Soc Nephrol. 2021.

clinical_trial2021
4

Martinez FM, Brown DL, Garcia RH. Treatment Outcomes in C3 Glomerulopathy: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Complement 3 Glomerulopathy C4087273. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy